Latest SEC Filings — Page 17
Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.
Purple Innovation Cuts 2026 Revenue Guidance Amidst Q1 Loss; Appoints New CFO
UCB filing
PACCAR Reports Q1 Adjusted EPS Decline Amidst Revenue Drop, Despite Positive Outlook
Sysco Reports Mixed Q3 Results with Strong Sales, Volume Growth, and Reaffirmed Full-Year EPS Guidance
Hadron Energy Secures Strategic Investment and Multi-Project Nuclear Deployment Framework Ahead of Merger Vote
Allarity Therapeutics Secures US Patent Allowance for Stenoparib DRP® Companion Diagnostic
Patterson-UTI Energy Extends Maturity for $450M Revolving Credit Facility
NAMI filing
Celestica Amends Credit Agreement, Boosts Revolver to $1.75B and Extends Maturity
Amentum Holdings Refinances $3.991 Billion in Senior Secured Debt Facilities
Smithfield Foods Reports Record Q1 Results, Exceeding Expectations and Reaffirming Outlook
Sleep Number Secures $25M Emergency Loan and Forbearance Agreement Amidst Covenant Defaults
BSAA filing
Smithfield Foods Reports Strong Q1 Earnings, Advances Major Strategic Initiatives
Skycorp Solar Regains Nasdaq Minimum Bid Price Compliance, Averting Delisting Risk
Franklin Electric Reports Strong Q1 2026 Results with Double-Digit Sales and EPS Growth, Maintains Full-Year Guidance
Sports Entertainment Gaming Global Corp Secures Exclusive Partnership with Polymarket for Sports.com Predict Platform
Central Bancompany Reports Strong Q1 2026 Results, Boosts Dividend by 118%, and Executes $32M Share Buyback
BioCardia Secures Key Japanese Patent for Heart3D™ Imaging Software
Warrant Exercise Price Slashed, 15M Shares Registered for Resale Amidst Financial Distress
Warrant Exercise Price Slashed, Massive Dilution Risk Looms Amidst Financial Distress
Hope Bancorp Reports Strong Q1 Earnings, Raises Loan Growth Outlook, and Advances Strategic Acquisition
LULU filing
Cullinan Therapeutics Establishes New $200M At-The-Market Equity Offering Program
SDGR filing
Lululemon Appoints Unilever Veteran Esi Eggleston Bracey to Board Amid Leadership Transition
Wave Life Sciences Reports Strong Q1 Financials with 4x Revenue Growth and Advances Key Pipeline Programs
Schrodinger Seeks Shareholder Approval for 3 Million Share Increase to Equity Incentive Plan
Cardiol Therapeutics Expands Phase III MAVERIC Trial Network, Reaches 75% Patient Enrollment
Hut 8 Subsidiary Prices $3.25 Billion Senior Secured Notes for 245MW Data Center Project